IMCD NV (XAMS:IMCD)
€ 132.6 -1.5 (-1.12%) Market Cap: 7.55 Bil Enterprise Value: 8.43 Bil PE Ratio: 25.85 PB Ratio: 4.38 GF Score: 90/100

Q1 2023 IMCD NV Earnings Call Transcript

Apr 26, 2023 / 07:00AM GMT
Release Date Price: €137.9 (-3.97%)
Operator

Please go ahead.

Pieter C. J. van der Slikke
IMCD N.V. - CEO & Member of Management Board

Good morning, everyone. As usual, I'm here with Hans Kooijmans and we're happy to take your questions in a moment.

My name is Pieter Slikke. We started 2023 with a strong first quarter with an EBITA growth of 6% and even adjusted for ForEx 8%. Certainly, when you realized that we grew Q1 2022 with 59%, we were able to hold revenue more or less at the same level as quarter 1, 2023, and we're able to increase our margin. The business segments in Life Science performed quite well.

In the industrial segments, we saw effects of destocking and slowing down of demand. We completed 2 acquisitions in Q1, 1 in the U.K. and 1 in China. Sunrise in China will give us a strong position in the beauty and personal care market in that country. We closed a small bolt-on acquisition in Sweden last week, signed 2 deals in South Africa and India, and we expect to do more acquisitions in the course of this year. So we have proven resilience throughout our history. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot